Why are African Americans less Likely to Survive Certain Cancers?

	Tweet

African Americans are more likely than other races to die from breast, prostate and ovarian cancers, but this disparity is not due to poverty or inferior healthcare, a first-of-its-kind study has found.

Researchers followed more than 19,000 patients who were enrolled in cancer clinical trials conducted by the Southwest Oncology Group, a National Cancer Institute-funded clinical trials national cooperative. Patients of all races received the same advanced treatments by the same doctors.

“It was a level playing field for everyone, with the same quality care,” said lead author Dr. Kathy Albain. “So our findings cast doubt on a prevailing theory that African Americans have lower cancer survival rates because of poverty, poor access to quality care or other socioeconomic factors.” Albain is a breast and lung cancer specialist at Loyola University Health System’s Cardinal Bernardin Cancer Center.

If poverty or other socioeconomic factors were to blame, then the survival gap should exist for all cancers. But the study, published in the Journal of the National Cancer Institute, found there was no statistically significant association between race and survival for lung and colon cancers, leukemia, lymphoma or myeloma.

“The good news for African Americans is that for most common cancers, they have the same survival rates as all other races,” Albain said.

The cancers that did show survival gaps—breast, prostate and ovarian—are gender-related. The findings therefore suggest that the survival gap is due to a complex interaction of biologic factors in the tumor and inherited variations in common genes that control metabolism of drugs and hormones, Albain said. People with different patterns of these genes metabolize cancer drugs and their own hormones differently, and experience different side effects.

“We are actively conducting new research based on these findings to explore interactions among tumor biology, treatment, sex, race, inherited genes and survival,” Albain said.

Dr. Patrick Stiff, director of the Cardinal Bernardin Cancer Center, said: “This groundbreaking study will provide investigators with a road map for future research that will improve outcomes of patients of all races and socioeconomic status.”

Researchers identified 19,457 adult cancer patients enrolled in 35 Southwest Oncology Group clinical trials who were followed for at least 10 years after treatment. Twelve percent of the patients were African American. During the course of the study, African Americans were 49 percent more likely than other races to die from early-stage, postmenopausal breast cancer; 41 percent more likely to die from early stage, premenopausal breast cancer; 61 percent more likely to die from advanced-stage ovarian cancer and 21 percent more likely to die from advanced-stage prostate cancer.

Albain is a professor in the Department of Medicine, Division of Hematology/Oncology, Loyola University Chicago Stritch School of Medicine. Her co-authors are Joseph Unger and John Crowley of the Southwest Oncology Group Statistical Center, Dr.Charles Coltman of the University of Texas Health Science Center and Dr. Dawn Hershman of Columbia University College of Physicians and Surgeons.

The study was funded by the National Cancer Institute.

Based in the western suburbs of Chicago, Loyola University Health System is a quaternary care system with a 61-acre main medical center campus, the 36-acre Gottlieb Memorial Hospital campus and 28 primary and specialty care facilities in Cook, Will and DuPage counties. The medical center campus is conveniently located in Maywood, 13 miles west of the Chicago Loop and 8 miles east of Oak Brook, Ill. The heart of the medical center campus, Loyola University Hospital, is a 561-licensed bed facility. It houses a Level 1 Trauma Center, a Burn Center and the Ronald McDonald® Children’s Hospital of Loyola University Medical Center. Also on campus are the Cardinal Bernardin Cancer Center, Loyola Outpatient Center, Center for Heart & Vascular Medicine and Loyola Oral Health Center as well as the LUC Stritch School of Medicine, the LUC Marcella Niehoff School of Nursing and the Loyola Center for Fitness. Loyola’s Gottlieb campus in Melrose Park includes the 264-bed community hospital, the Gottlieb Center for Fitness and the Marjorie G. Weinberg Cancer Care Center.

Source: Loyola University Health System

RELATED STORIES:
Declining breast cancer incidence in Canada with declining HRT usage   “Glycemic load” of diet tied to breast cancer risk   Israeli woman gives birth after ovary transplant   Recurrence of breast cancer after more than 10 years is an important indicator of survival   Shorter radiation course as effective as standard therapy for prostate cancer recurrence   Childhood Cancer Survivors Show Inadequate Screening for Breast Cancer   Team identifies new breast cancer tumor suppressor and how it works   Breast density associated with increased risk of cancer recurrence   Breast symmetry can be early indicator of breast cancer   New study suggests Concord grape juice may provide protection against breast cancer   Extra Radiation Dose Prevents Breast Cancer Return in Young Women   Fat intake increases prostate cancer risk   Gene fuelled transporter causes breast cancer cells to self-destruct   10 Years of Providing Support, Information and Hope to Young Women Diagnosed with Breast Cancer   Mechanisms Involved with Tumor Relapse Identified   Pre-surgery sessions boost prostate patients’ mood   MRI may cause more harm than good in newly diagnosed early breast cancer   Radiation ups risk of breast cancer in young women   New drug comb may lengthen ovarian cancer survival   Suspicion Lingers Over Bisphenol A and Breast Cancer   Cell of Origin Identified for Common Type of Breast Cancer   Researchers Find Ovarian Cancer Risk Related To Inherited Inflammation Genes

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]